Experts discussion of recent efficacy and safety data on JAK inhibitors in managing RA, from Clinical Care Options (CCO)
Drs. Stanley Cohen and Janet Pope on the latest clinical trials and real-world evidence regarding JAK inhibitor efficacy from Clinical Care Options (CCO)
Clinical Care Options (CCO): infectious diseases physician on use of postexposure chemoprophylaxis for patients with rheumatologic disorders who are at high-risk for influenza complications
Clinical Care Options (CCO) presents expert faculty discussing options for the treatment and care of patients with rheumatic disease during flu season.